Dr Jon Dusting

Dr Jon Dusting is an expert in advanced imaging-based measurement technologies and their application to a wide range of engineering challenges. As Chief Research Officer at 4DMedical, Dr Dusting plays a central role in the research and development of the company’s groundbreaking lung function imaging analysis products.

He earned a Bachelor of Engineering (Honours), majoring in Mechanical Engineering, from Monash University, followed by postgraduate studies in the Department of Mechanical Engineering under the supervision of the late Professor John Sheridan and Professor Kerry Hourigan, where he completed the department’s first PhD in biological fluid dynamics.

After completing his PhD in 2006, Dr Dusting held postdoctoral research positions at King’s College and Imperial College in London. He later became a Senior Research Scientist at Schlumberger Cambridge Research, where he delivered numerous interdisciplinary technology projects at the intersection of academia and industry.

In 2018, Dr Dusting relocated from the United Kingdom to Los Angeles and joined 4DMedical during a pivotal period of rapid growth as the company transitioned from its start-up phase. He returned to Australia in late 2020 to lead a $29 million Medical Research Future Fund Frontiers grant project aimed at developing a novel 4D lung function scanner and establishing a dedicated radiation laboratory, prototyping space, and assembly facility in Port Melbourne. The first XV Scanner was installed at Prince of Wales Hospital in Sydney one year later.

Currently based at 4DMedical’s headquarters at Melbourne Connect,Dr Dusting is a member of the Engineering executive team and leads both the Research and Hardware teams in a fast-paced, dynamic environment. His work focuses on creating innovative software and scanner technologies that leverage both artificial intelligence and traditional methods of image analysis to map airflow and blood flow in all regions of the lungs—ultimately supporting clinicians in the diagnosis and treatment of lung diseases.

While these projects present stimulating technical challenges and opportunities for innovation, they also involve navigating the complexities of clinical trials, medical device translation, and commercialisation—especially in an era of rapidly evolving AI technologies. Dr Dusting also shares his expertise in these areas by mentoring tech start-up founders through the TRAM Air program.